Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

17.500
-1.250-6.67%
Volume:4.97M
Turnover:87.44M
Market Cap:28.46B
PE:8.38
High:18.300
Open:18.300
Low:17.340
Close:18.750
52wk High:20.400
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:4.67
T/O Rate:2.26%
Dividend:0.88
Dividend Rate:5.01%
EPS(LYR):2.088
ROE:7.86%
ROA:2.41%
PB:0.66
PE(LYR):8.38
PS:0.32

Loading ...

Baiyunshan Pharmaceutical Announces RMB0.45 Final Dividend for FY2025

Bulletin Express
·
Mar 20

BAIYUNSHAN PH (00874) Announces Final Dividend of HK$0.45 Per Share

Stock News
·
Mar 20

BAIYUNSHAN PH Reports Annual Results with 5.21% Increase in Net Profit

Stock News
·
Mar 20

GPC and Baiyunshan Launch Phase One of Financial Transformation Initiative

Deep News
·
Mar 17

Baiyunshan Pharma's Subsidiary Gets Nod for Xu Han Ting Granules' Trial As Respiratory Treatment

MT Newswires Live
·
Mar 17

Hong Kong Market Announcements: Ant Group's Acquisition of Bright Smart Receives Approval, Trading Resumes March 17

Stock News
·
Mar 17

Clinical Trial Application for Baiyunshan's Xuhanting Granules in Pediatric Recurrent Respiratory Infections Receives Approval

Stock News
·
Mar 16

Baiyunshan Receives SSE Approval for Guangzhou Pharmaceutical Receivables ABS Listing

Stock News
·
Mar 16

Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results

Bulletin Express
·
Mar 10

JPMorgan Reduces Stake in BAIYUNSHAN PH, Selling 207,200 Shares at HK$18.75 Each

Deep News
·
Mar 09

JPMorgan Reduces Stake in Baiyunshan by 207,200 Shares at HK$18.75 Per Share

Stock News
·
Mar 06

BAIYUNSHAN PH (00874) Announces Board Composition and Committee Structure

Bulletin Express
·
Mar 06

BAIYUNSHAN PH (00874) Appoints Huang Xuezhen as New Authorized Representative

Stock News
·
Mar 06

Guangzhou Baiyunshan Pharmaceutical - Cheng Ning Resigning From Her Positions as Vice Chairperson and an Executive Director

THOMSON REUTERS
·
Mar 06

Guangzhou Baiyunshan (00874.HK, 600332.SSE) Reports Unchanged Share Capital in February 2026

Bulletin Express
·
Mar 03

Baiyunshan Pharmaceutical's Subsidiaries Apply Drugs for Renewal in China's Centralized Procurement

MT Newswires Live
·
Feb 12

Baiyunshan Pharmaceutical Gets China Nod for Changes to Mouthwash Spray's Registration

MT Newswires Live
·
Feb 11

Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence

Stock News
·
Feb 11

Eight Government Bodies Issue Plan to Boost Traditional Chinese Medicine Industry Development

Stock News
·
Feb 06

JPMorgan Boosts Stake in Baiyunshan by 360,600 Shares at HK$18.85 Each

Stock News
·
Feb 04